Kojic Acid

1. INCI & CAS

INCI: Kojic Acid · CAS: 501-30-4

2. Role in the formula

Kojic acid is restricted or under review in several markets, including EU SCCS opinions on leave-on use. This guide does not claim a whitening drug. Confirm the destination limit before any scale-up. If the market disallows it, leave it out.

3. Typical use levels (formulation guide)

• Only where the destination rule allows, often at or below 1%

Dissolve carefully. Protect from light and air. Do not assume EU leave-on acceptance.

4. Regulatory sources & global compliance

• Use CosIng's information on Kojic Acid as a reference, then verify the specific grade and intended use under market rules.
• Regulation (EC) No 1223/2009 requires an assessment of the safety of the final cosmetic containing Kojic Acid for the product in its final form.
• Use the supplier TDS to confirm grade-specific details for Kojic Acid and review the destination market's requirements.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; the listed level does not itself confer drug or OTC status and the finished formula still needs patch and stability testing.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; for oxidation-sensitive formulas, consider an airless or pump pack; check the finished batch's stability and package compatibility.

7. Claims language (Do / Don’t)

• Names kojic acid only as a restricted cosmetic guide

• This formulation entry does not support drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The formulation record for Kojic Acid does not confirm whitening, treatment of acne, perspiration control, sun protection, or hair growth.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

The glycerin note covers its polyol-humectant role in washes, gels, and emulsions and gives a formulation guide level.

3. Typical use levels (formulation guide)

• For gels and serums, the recorded level is 3–8%.
• The level shown for creams is 2–5% as a formulation guide.
• Formulation guidance for rinse-off: 2–4%.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Regulatory sources & global compliance

• CosIng information about Glycerin does not itself authorize a particular grade or finished cosmetic.
• Regulation (EC) No 1223/2009 requires the completed product containing Glycerin to receive its own safety assessment before the finished product is marketed.
• Confirm the received Glycerin grade against supplier documentation, then verify the intended market's filing requirements.

5. Safety & risk assessment

The use-level note is a reference for cosmetic formulation; it is not evidence of drug approval or OTC authorization and the final formula should undergo patch and stability assessment.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; where oxidation is a concern, evaluate airless or pump packaging; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• The cosmetic concept for Glycerin in this entry centers on humectant function.

• This cosmetic guide provides no basis for drug claims, cure claims, or a certification that is absent from the product records.
• This guide to Glycerin does not establish skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

As a hydrocarbon emollient, squalane offers stability; the grade in this guide is plant-derived rather than mineral oil.

3. Typical use levels (formulation guide)

• For gel-creams, the recorded level is 2–6% as a formulation guide.
• The level shown for dry oils is 10–30% for the formula.
• Balms: 5–15% in this reference.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Regulatory sources & global compliance

• An entry for Squalane in CosIng is not authorization for a material grade or completed cosmetic; review local requirements.
• Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Squalane before the finished product is marketed.
• Compare the received Squalane material with its supplier specification and review destination-market filing needs.

5. Safety & risk assessment

Read the recorded level as a cosmetic formulation guide; this reference is not approval for drug use or OTC marketing and the completed formula still requires stability and patch testing.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; evaluate packaging against the formula's susceptibility to oxidation; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Squalane highlights a light-emollient role.

• This ingredient reference cannot verify therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• The ingredient record for Squalane does not support whitening, treatment of acne, perspiration control, sun protection, or hair growth.